Region Skane Hassleholm Hospital

The Hip and Knee unit at Region Skane Hassleholm Hospital is conducting research focused on Acute Ischemic Stroke and high‑risk transient ischemic attacks, integrating diagnostic imaging and therapeutic techniques to improve patient outcomes.

• Assessing a novel oral anticoagulant for reducing recurrent stroke events
• Exploring early initiation of targeted therapy within hours of symptom onset
• Measuring functional recovery three months after treatment

These studies aim to provide safer, more effective options for preventing further cerebrovascular events and enhancing recovery after stroke.

In the area of Musculoskeletal Diseases, investigators are evaluating strategies to lower infection risk following hip replacement surgeries.

• Testing antibiotic‑impregnated bone grafts as a protective measure
• Comparing infection rates two years post‑arthroplasty
• Analyzing long‑term implant stability and patient safety

The goal is to reduce prosthetic joint infections, thereby improving the durability of hip arthroplasties and patient quality of life.

Research within the Operative Procedures field examines anesthesia choices for same‑day discharge after primary total knee and hip replacements.

• Comparing general anaesthesia with spinal anaesthesia on discharge success
• Tracking readmission rates within 48 hours of surgery
• Evaluating patient comfort and postoperative mobility

Findings will guide best practices for outpatient joint surgery, aiming to increase same‑day discharge rates while maintaining safety.

The site’s investigations also address Cardiovascular Diseases, focusing on novel anticoagulant therapy to prevent further ischemic events after an initial stroke.

• Determining efficacy of a new oral anticoagulant in reducing stroke recurrence
• Monitoring safety profile and bleeding risk
• Assessing overall cardiovascular outcomes over a multi‑year period

This work seeks to expand treatment options for patients at high risk of subsequent cardiovascular complications.